R&D
For a better future SCM Lifescience will do its best
Result
  • Phase 1/2 trials of human bone marrow–derivedclonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis
    Hyun-Min Seo, MD, PhD, Bark-Lynn Lew, MD, PhD, Yang Won Lee, MD, PhD, Sang Wook Son, MD, PhD, Chang Ook Park, MD, PhD, Young Lip Park, MD, PhD, et al
    J Allergy Clin Immunol 2024;154:965-73.
1